Your browser doesn't support javascript.
loading
SEOM clinical guidelines on cardiovascular toxicity (2018)
Virizuela, JA; García, AM; Peñas, R de las; Santaballa, A; Andrés, R; Beato, C; Cruz, S de la; Gavilá, J; González-Santiago, S; Fernández, TL.
Affiliation
  • Virizuela, JA; Complejo Hospitalario Regional Virgen Macarena. Servicio de Oncología Médica. Seville. Spain
  • García, AM; Complejo Asistencial Universitario de Salamanca (CAUSA). Servicio de Cardiología. Salamanca. Spain
  • Peñas, R de las; Hospital Provincial de Castellón. Servicio de Oncología Médica. Castellón de la Plana. Spain
  • Santaballa, A; Hospital Universitari I Politècnic la Fe. Servicio de Oncología Médica. Valencia. Spain
  • Andrés, R; Hospital Clínico Universitario Lozano Blesa. Servicio de Oncología Médica. Zaragoza. Spain
  • Beato, C; Complejo Hospitalario Regional Virgen Macarena. Servicio de Oncología Médica. Sevilla. Spain
  • Cruz, S de la; Complejo Hospitalario de Navarra. Servicio de Oncología Médica. Pamplona. Spain
  • Gavilá, J; Fundación Instituto Valenciano de Oncología (IVO). Servicio de Oncología Médica. Valencia. Spain
  • González-Santiago, S; Complejo Hospitalario Universitario de Cáceres. Servicio de Oncología Médica. Cáceres. Spain
  • Fernández, TL; Hospital Universitario La Paz. Servicio de Cardiología. Madrid. Spain
Clin. transl. oncol. (Print) ; 21(1): 94-105, ene. 2019. tab, graf
Article in English | IBECS | ID: ibc-183348
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients
RESUMEN
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Drug-Related Side Effects and Adverse Reactions / Cardiotoxicity / Antineoplastic Agents Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2019 Document type: Article Institution/Affiliation country: Complejo Asistencial Universitario de Salamanca (CAUSA)/Spain / Complejo Hospitalario Regional Virgen Macarena/Spain / Complejo Hospitalario Universitario de Cáceres/Spain / Complejo Hospitalario de Navarra/Spain / Fundación Instituto Valenciano de Oncología (IVO)/Spain / Hospital Clínico Universitario Lozano Blesa/Spain / Hospital Provincial de Castellón/Spain / Hospital Universitari I Politècnic la Fe/Spain / Hospital Universitario La Paz/Spain
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Drug-Related Side Effects and Adverse Reactions / Cardiotoxicity / Antineoplastic Agents Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2019 Document type: Article Institution/Affiliation country: Complejo Asistencial Universitario de Salamanca (CAUSA)/Spain / Complejo Hospitalario Regional Virgen Macarena/Spain / Complejo Hospitalario Universitario de Cáceres/Spain / Complejo Hospitalario de Navarra/Spain / Fundación Instituto Valenciano de Oncología (IVO)/Spain / Hospital Clínico Universitario Lozano Blesa/Spain / Hospital Provincial de Castellón/Spain / Hospital Universitari I Politècnic la Fe/Spain / Hospital Universitario La Paz/Spain